Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$270.18-5.05 (-1.84%)
Delayed quote: Sep 8, 2026, 3:15 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 3:15 PM EDT
The latest quarterly inventory is $15.14 Billion with a quarter-over-quarter change of +3.85%. Inventory includes raw materials, work-in-progress, and finished goods held by a company for sale or for use in production.
Reported quarterly inventory; no daily interpolation.
$15.14B
$15.14 Billion
+3.85%
vs. $14.58B prior quarter
96
Quarters of data available
| Period | Inventory | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $15.14B | +$561.00M | +3.85% |
| Quarter ended Mar 2026 | $14.58B | +$392.00M | +2.76% |
| Quarter ended Dec 2025 | $14.19B | +$45.00M | +0.32% |
| Quarter ended Sep 2025 | $14.15B | +$734.00M | +5.47% |
| Quarter ended Jun 2025 | $13.41B | +$753.00M | +5.95% |
| Quarter ended Mar 2025 | $12.66B | +$215.00M | +1.73% |
| Quarter ended Dec 2024 | $12.44B | −$159.00M | -1.26% |
| Quarter ended Sep 2024 | $12.60B | +$434.00M | +3.57% |
| Quarter ended Jun 2024 | $12.17B | +$786.00M | +6.91% |
| Quarter ended Mar 2024 | $11.38B | +$202.00M | +1.81% |
| Quarter ended Dec 2023 | $11.18B | −$17.00M | -0.15% |
| Quarter ended Oct 2023 | $11.20B | −$1.69B | -13.11% |
| Quarter ended Jul 2023 | $12.89B | +$79.00M | +0.62% |
| Quarter ended Apr 2023 | $12.81B | +$2.54B | +24.75% |
| Quarter ended Dec 2022 | $10.27B | −$1.41B | -12.05% |
| Quarter ended Oct 2022 | $11.68B | +$238.00M | +2.08% |
| Quarter ended Jul 2022 | $11.44B | +$447.00M | +4.07% |
| Quarter ended Apr 2022 | $10.99B | +$603.00M | +5.81% |
| Quarter ended Dec 2021 | $10.39B | +$0 | 0.00% |
| Quarter ended Oct 2021 | $10.39B | +$287.00M | +2.84% |
| Quarter ended Jul 2021 | $10.10B | +$148.00M | +1.49% |
| Quarter ended Apr 2021 | $9.95B | +$608.00M | +6.51% |
| Quarter ended Dec 2020 | $9.34B | −$255.00M | -2.66% |
| Quarter ended Sep 2020 | $9.60B | +$175.00M | +1.86% |
| Quarter ended Jun 2020 | $9.42B | +$556.00M | +6.27% |
| Quarter ended Mar 2020 | $8.87B | −$152.00M | -1.69% |
| Quarter ended Dec 2019 | $9.02B | −$153.00M | -1.67% |
| Quarter ended Sep 2019 | $9.17B | −$90.00M | -0.97% |
| Quarter ended Jun 2019 | $9.26B | +$177.00M | +1.95% |
| Quarter ended Mar 2019 | $9.09B | +$487.00M | +5.66% |
| Quarter ended Dec 2018 | $8.60B | −$79.00M | -0.91% |
| Quarter ended Sep 2018 | $8.68B | −$132.00M | -1.50% |
| Quarter ended Jul 2018 | $8.81B | −$204.00M | -2.26% |
| Quarter ended Apr 2018 | $9.01B | +$249.00M | +2.84% |
| Quarter ended Dec 2017 | $8.77B | −$756.00M | -7.94% |
| Quarter ended Oct 2017 | $9.52B | −$178.00M | -1.84% |
| Quarter ended Jul 2017 | $9.70B | +$821.00M | +9.25% |
| Quarter ended Apr 2017 | $8.88B | +$734.00M | +9.01% |
| Quarter ended Dec 2016 | $8.14B | −$344.00M | -4.05% |
| Quarter ended Oct 2016 | $8.49B | −$35.00M | -0.41% |
| Quarter ended Jul 2016 | $8.52B | +$353.00M | +4.32% |
| Quarter ended Apr 2016 | $8.17B | +$117.00M | +1.45% |
| Quarter ended Dec 2015 | $8.05B | −$153.00M | -1.86% |
| Quarter ended Sep 2015 | $8.21B | −$92.00M | -1.11% |
| Quarter ended Jun 2015 | $8.30B | +$213.00M | +2.63% |
| Quarter ended Mar 2015 | $8.09B | −$99.00M | -1.21% |
| Quarter ended Dec 2014 | $8.18B | −$235.00M | -2.79% |
| Quarter ended Sep 2014 | $8.42B | +$264.00M | +3.24% |
| Quarter ended Jun 2014 | $8.15B | +$146.00M | +1.82% |
| Quarter ended Mar 2014 | $8.01B | +$131.00M | +1.66% |
| Quarter ended Dec 2013 | $7.88B | −$246.00M | -3.03% |
| Quarter ended Sep 2013 | $8.12B | +$302.00M | +3.86% |
| Quarter ended Jun 2013 | $7.82B | +$131.00M | +1.70% |
| Quarter ended Mar 2013 | $7.69B | +$196.00M | +2.62% |
| Quarter ended Dec 2012 | $7.50B | −$314.00M | -4.02% |
| Quarter ended Sep 2012 | $7.81B | +$112.00M | +1.46% |
| Quarter ended Jul 2012 | $7.70B | +$897.00M | +13.19% |
| Quarter ended Apr 2012 | $6.80B | +$515.00M | +8.19% |
| Quarter ended Dec 2011 | $6.29B | −$143.00M | -2.22% |
| Quarter ended Oct 2011 | $6.43B | +$15.00M | +0.23% |
| Quarter ended Jul 2011 | $6.41B | +$213.00M | +3.44% |
| Quarter ended Apr 2011 | $6.20B | +$822.00M | +15.28% |
| Quarter ended Dec 2010 | $5.38B | −$31.00M | -0.57% |
| Quarter ended Oct 2010 | $5.41B | +$338.00M | +6.67% |
| Quarter ended Jul 2010 | $5.07B | −$237.00M | -4.46% |
| Quarter ended Apr 2010 | $5.31B | +$128.00M | +2.47% |
| Quarter ended Dec 2009 | $5.18B | −$388.00M | -6.97% |
| Quarter ended Sep 2009 | $5.57B | +$96.00M | +1.75% |
| Quarter ended Jun 2009 | $5.47B | +$113.00M | +2.11% |
| Quarter ended Mar 2009 | $5.36B | +$307.00M | +6.08% |
| Quarter ended Dec 2008 | $5.05B | −$421.00M | -7.69% |
| Quarter ended Sep 2008 | $5.47B | −$227.00M | -3.98% |
| Quarter ended Jun 2008 | $5.70B | +$125.00M | +2.24% |
| Quarter ended Mar 2008 | $5.58B | +$465.00M | +9.10% |
| Quarter ended Dec 2007 | $5.11B | −$304.00M | -5.62% |
| Quarter ended Sep 2007 | $5.41B | +$259.00M | +5.02% |
| Quarter ended Jul 2007 | $5.16B | +$108.00M | +2.14% |
| Quarter ended Apr 2007 | $5.05B | +$158.00M | +3.23% |
| Quarter ended Dec 2006 | $4.89B | +$440.00M | +9.89% |
| Quarter ended Oct 2006 | $4.45B | +$136.00M | +3.15% |
| Quarter ended Jul 2006 | $4.31B | +$73.00M | +1.72% |
| Quarter ended Apr 2006 | $4.24B | +$281.00M | +7.10% |
| Quarter ended Dec 2005 | $3.96B | −$56.00M | -1.39% |
| Quarter ended Oct 2005 | $4.01B | +$52.00M | +1.31% |
| Quarter ended Jul 2005 | $3.96B | +$149.00M | +3.91% |
| Quarter ended Apr 2005 | $3.81B | +$70.00M | +1.87% |
| Quarter ended Dec 2004 | $3.74B | +$75.00M | +2.04% |
| Quarter ended Sep 2004 | $3.67B | +$141.00M | +4.00% |
| Quarter ended Jun 2004 | $3.53B | +$6.00M | +0.17% |
| Quarter ended Mar 2004 | $3.52B | −$66.00M | -1.84% |
| Quarter ended Dec 2003 | $3.59B | −$151.00M | -4.04% |
| Quarter ended Sep 2003 | $3.74B | +$59.00M | +1.60% |
| Quarter ended Jun 2003 | $3.68B | +$139.00M | +3.93% |
| Quarter ended Mar 2003 | $3.54B | +$238.00M | +7.21% |
| Quarter ended Dec 2002 | $3.30B | +$48.00M | +1.47% |
| Quarter ended Sep 2002 | $3.25B | N/A | N/A |